New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
Behavioral effects of the kappa opioid receptor partial agonist nalmefene in tests relevant to depression - ScienceDirect
G protein signaling–biased mu opioid receptor agonists that produce sustained G protein activation are noncompetitive agonists | PNAS
Behavioral effects of the kappa opioid receptor partial agonist nalmefene in tests relevant to depression - ScienceDirect
Mu Agonist Opioids and Kappa Opioids | Download Table
Behavioral effects of the kappa opioid receptor partial agonist nalmefene in tests relevant to depression - ScienceDirect
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action | PNAS
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
The role of the opioid system in decision making and cognitive control: A review | SpringerLink
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
A Novel Kappa Opioid Receptor Agonist May Unlock New Treatment Strategies for Pain | Pain Research Forum
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Behavioral effects of the kappa opioid receptor partial agonist nalmefene in tests relevant to depression - ScienceDirect
Antagonists of the kappa opioid receptor - ScienceDirect
The atomistic level structure for the activated human κ-opioid receptor bound to the full Gi protein and the MP1104 agonist | PNAS
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Mu Agonist Opioids and Kappa Opioids | Download Table
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
